Clinical Trial Update: Study of Irinotecan Liposome Injection in Patients With Advanced Breast Cance [Phase 1]

View source ↗

Summary

Phase 1 study of irinotecan liposome injection in patients with advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Irinotecan liposome injection (irinotecan liposome injection)

Snippet

Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd. | Conditions: Advanced Breast Cancer | Phase 1 | Status: COMPLETED